• ONDALENZ Oral Dispersible Tablet is indicated for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy.
• Active ingredient: Ondansetron 4mg
• Indication:
o For the prevention of nausea and vomiting o For the prevention of postoperative nausea and/or vomiting.
• Dosage and administration:
o It should be described by physician.
o o It is not indicated for the treatment of children less than 4 years old.